Skip to main content

Table 1 Comorbidities of included patients

From: Triple platelet inhibition in intracranial thrombectomy with additional acute cervical stent angioplasty due to tandem lesion: a retrospective single-center analysis

  

n

mRS 90 d

OR (95%-KI)

p-value*

3–6

0–2

pre mRS

0

101

45 (44.6%)

56 (55.4%)

-

 
 

1

39

23 (59.0%)

16 (41.0%)

0.56 (0.26–1.19)

0.136

 

2

24

17 (70.8%)

7 (29.2%)

0.33 (0.12–0.89)

0.024

 

3

12

12 (100%)

0 (0%)

-

< 0.001

AF

no

147

73 (49.7%)

74 (50.3%)

  
 

yes

29

24 (82.8%)

5 (17.2%)

0.21 (0.07–0.59)

0.001

diabetes

no

145

75 (51.7%)

70 (48.3%)

  
 

yes

31

22 (71.0%)

9 (29.0%)

0.44 (0.19–1.03)

0.072

cholesterol

no

149

86 (57.7%)

63 (42.3%)

  
 

yes

27

11 (40.7%)

16 (59.3%)

1.99 (0.86–4.61)

0.140

hypertension

no

67

41 (61.2%)

26 (38.8%)

  
 

yes

109

56 (51.4%)

53 (48.6%)

1.49 (0.80–2.78)

0.216

current tobacco smoking

no

138

77 (55.8%)

61 (44.2%)

  
 

yes

38

20 (52.6%)

18 (47.4%)

1.14 (0.55–2.34)

0.854

cardiac disease

no

132

62 (47.0%)

70 (53.0%)

  
 

yes

44

35 (79.5%)

9 (20.5%)

0.23 (0.10–0.53)

< 0.001

amount of comorbidities

0

21

13 (61.9%)

8 (38.1%)

  

(AF-cardiac disease)

1

49

22 (44.9%)

27 (55.1%)

  
 

2

56

31 (55.4%)

25 (44.6%)

  
 

3

32

19 (59.4%)

13 (40.6%)

  
 

4

13

8 (61.5%)

5 (38.5%)

  
 

5

3

2 (66.7%)

1 (33.3%)

  
 

6

2

2 (100%)

0 (0%)

  
  1. * Exact Fisher-test